Cytokine levels and inflammatory responses in developing late-phase allergic reactions in the skin

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 1, 1997, Pages 104-109

  Zweiman, Burton ^a   Kaplan, Allen P ^b   Tong, Lijuan ^b   Moskovitz, Anne R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b STONY BROOK UNIVERSITY   (United States)

Author keywords

Allergic; Chemokines; Cytokines; Inflammation; Late phase; Skin chamber

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6;

ALLERGY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTAMINE RELEASE; HUMAN; IMMUNOREGULATION; LEUKOCYTE ACTIVATION; PATHOGENESIS; PRIORITY JOURNAL; SKIN ALLERGY;

EID: 0030853853     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70201-X     Document Type: Article

References (24)

1. Zweiman B. The late-phase reaction: role of IgE, its receptor and cytokine. Curr OP Immunol 1993;5:950-5.
2. Bochner BS, Charlesworth EN, Lichtenstein LM, Deerse CP, Gilles S, Dinarello CA, Schleimer, RP. Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol 1990;830-9.
3. Massey W, Friedman B, Kaio M, Cooper P, Kagey-Sobotka A, Lichtenstein LM, et al. Appearance of GM-CSF activities at allergen-challenged cutaneous late-phase reaction. J Immunol 1993;150:1084-92.
4. Lee CE, Newland MW, Teaford HG, Villacis BF, Dixon PS, Valtheer S, Yeh CH, et al. Interleukin-6 is released with the cutaneous response to allergen challenge in atopic individuals. J Allergy Clin Immunol 1992;89:1010-20.
5. Lemanske RF, Jr., Kaliner MA. Late phase reactions. In: Middleton E, Jr., Reed CE, Ellis EF, Adkinson NF, Jr., Yunginger JW, Busse WW, editors. Allergy: principles and practice. 4th ed., St. Louis: Mosby, 1993:320-61.
6. Zweiman B, Kucich U, Shalit M, von Allmen C, Moskovitz A, Weinbaum G, et al. Release of lactoferrin and elastase in human allergic skin reactions. J Immunol 1990;144:3953-60.
7. Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol 1996;97:104-12.
8. Kuna P, Reddigari SR, Schall TJ, Rucinski D, Sadick M, Kaplan AP, et al. Characterization of the human basophil response to cytokines, growth factors and histamine releasing factors of the intercrine/chemokine family. J Immunol 1993;150:1932-43.
9. Zweiman B. Mediators of allergic inflammation in the skin. Clin Allergy 1988;18:419-33.
10. Shalit M, Valone FH, Atkins PC, Ratnoff WD, Goetzl E J, Zweiman B. Late appearance of phospholipid platelet activating factor and leukotriene B4 in human skin after repeated antigen challenge. J Allergy Clin Immunol 1989;83:691-6.
11. Horie S, Gleich G J, Kita H. Cytokines directly induce degranulation and Superoxide production from human eosinophils. J Allergy Clin Immunol 1996;98:371-81.
12. Zhang L, Redington AE, Holgate ST. RANTES: a novel mediator of allergic inflammation. Clin Exp Allergy 1994;24:899-904.
13. Broide DH, Lotz M, Cuomo AJ, Cobura DA, Federman EC, Wasserman SI, et al. Cytokines in symptomatic asthma airways. J Allergy Clin Immunol 1992;89:958-67.
14. Sim TC, Grant JA, Hilsmeier KA, Fukuda Y, Alam R. Pro-inflammatory cytokines in nasal secretions of allergic subjects after antigen challenge. Am J Respir Crit Care Med 1994;150:1038-48.
15. Kaplan AP, Kuna P, Reddigari SR. Chemokines as allergic mediators: relationship to histamine-releasing factors. Allergy 1994;49:495-501.
16. Brunner T, Heusser CH, Dahinden CA. Human peripheral blood basophils primed by interleukin-3 (IL-3) in response to IgE-receptor stimulation. J Exp Med 1993;177:605-11.
17. Swensson O, Schubert C, Christophers E, Schroeder JM. Inflammatory properties of NPA-1/IL-8 in human skin. J Invest Dermatol 1991;96:682-9.
18. Shute J. Interleukin-8 is a potent eosinophil chemoattractant. Clin Exp Allergy 1994;24:203-6.
19. Shalit M, Schwartz LB, von Allmen C, Atkins PC, Lavker RM, Zweiman B. Release of histamine and tryptase during continuous and interrupted cutaneous challenge with allergen in humans. J Allergy Clin Immunol 1989;50:41-51.
20. Ohnisshi T, Kita H, Werle D, Sun S, Sedgewick JB, Calhoun W J, et al. IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. Am Rev Respir Dis 1993;147:901-7.
21. Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, et al. Messenger RNA expression of the cytokine cluster IL-3, IL-4, IL-5, and GM-CSF in allergen-induced late phase reactions in atopic subjects. J Exp Med 1991;173:775-8.
22. Vowels BR, Rook AL, Cassin M, Zweiman B. Expressions of IL-4 and IL-5 mRNA in developing cutaneous late ahase reactions. J Allergy Clin Immunol 1995;96:92-6.
23. Zweiman B, Atkins PC, von Allmen C, Gleich GJ. Release of eosinophil granule proteins during IgE-mediated allergic skin reactions. J Allergy Clin Immunol 1991;87:984-91.
24. Martin LB, Kita H, Leiferman K, Gleich GJ. Eosinophils in allergy: role in disease, degranulation, and cytokines. Int Arch Allergy Immunol 1996;109:207-15.